Adeno-associated viral vectors for gene therapy of inherited retinal degenerations

Methods in Molecular Biology

Volumn 935, Issue , 2013, Pages 351-369

  Flannery, John G ^a   Visel, Meike ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adeno associated virus; Gene transfer; Retinal degeneration

Indexed keywords

ADENO ASSOCIATED VIRUS; ANIMAL; ARTICLE; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; METHODOLOGY; RETINA DEGENERATION;

ANIMALS; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; RETINAL DEGENERATION;

ADENO-ASSOCIATED VIRUS; ANIMALIA;

EID: 84871945466     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-080-9-25     Document Type: Article

References (31)

1. Deisseroth K (2011) Optogenetics. Nat Methods 8(1):26-29
2. Busskamp V, Duebel J, Balya D, Fradot M, Viney TJ, Siegert S, Groner AC, Cabuy E, Forster V, Seeliger M, Biel M, Humphries P, Paques M, Mohand-Said S, Trono D, Deisseroth K, Sahel JA, Picaud S, Roska B (2010) Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science 329(5990):413-417
3. Caporale N, Kolstad KD, Lee T, Tochitsky I, Dalkara D, Trauner D, Kramer R, Dan Y, Isacoff EY, Flannery JG (2011) LiGluR restores visual responses in rodent models of inherited blindness. Mol Ther 19(7): 1212-1219
4. Tian G, Zhou Y, Hajkova D, Miyagi M, Dinculescu A, Hauswirth WW, Palczewski K, Geng R, Alagramam KN, Isosomppi J, Sankila EM, Flannery JG, Imanishi Y (2009) Clarin-1, encoded by the Usher Syndrome III causative gene, forms a membranous microdomain: Possible role of clarin-1 in organizing the actin cytoskeleton. J Biol Chem 284(28): 18980-18993
5. Muto A, Ohkura M, Kotani T, Higashijima S, Nakai J, Kawakami K (2011) Genetic visualization with an improved GCaMP calcium indicator reveals spatiotemporal activation of the spinal motor neurons in zebra fi sh Proc Natl Acad Sci U S A 108(13):5425-5430
6. Greenberg KP, Pham A, Werblin FS (2011) Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism. Neuron 69(4):713-720
7. Xiao X, Li J, Samulski RJ (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72(3):2224-2232 (Pubitemid 28100780)
8. Allocca M, Doria M, Petrillo M, Colella P, Garcia-Hoyos M, Gibbs D, Kim SR, Maguire A, Rex TS, Di Vicino U, Cutillo L, Sparrow JR, Williams DS, Bennett J, Auricchio A (2008) Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest 118(5):1955-1964 (Pubitemid 351632397)
9. Wu Z, Yang H, Colosi P (2010) Effect of genome size on AAV vector packaging. Mol Ther 18(1):80-86
10. Dong B, Nakai H, Xiao W (2010) Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther 18(1):87-92
11. Dalkara D, Kolstad KD, Guerin KI, Hoffmann NV, Visel M, Klimczak RR, Schaffer DV, Flannery JG (2011) AAV mediated GDNF secretion from retinal glia slows down retinal degeneration in a rat model of retinitis pigmentosa. Mol Ther 19(9):1602-1608
12. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27(1):59-65
13. Bostick B, Ghosh A, Yue Y, Long C, Duan D (2007) Systemic AAV-9 transduction in mice is in fl uenced by animal age but not by the route of administration. Gene Ther 14(22): 1605-1609 (Pubitemid 350056232)
14. Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, Deleage G, Hallek M (1999) Genetic capsid modi fi cations allow ef fi cient retargeting of adeno-associated virus type 2. Nat Med 5(9):1052-1056 (Pubitemid 29439578)
15. Petrs-Silva H, Dinculescu A, Li Q, Min SH, Chiodo V, Pang JJ, Zhong L, Zolotukhin S, Srivastava A, Lewin AS, Hauswirth WW (2009) High-ef fi ciency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther 17(3):463-471
16. Schaffer DV, Maheshri N (2004) Directed evolution of AAV mutants for enhanced gene delivery. Conf Proc IEEE Eng Med Biol Soc 5:3520-3523 (Pubitemid 40035411)
17. Klimczak RR, Koerber JT, Dalkara D, Flannery JG, Schaffer DV (2009) A novel adeno-associated viral variant for ef fi cient and selective intravitreal transduction of rat Muller cells. PLoS One 4(10):e7467
18. Dalkara D, Kolstad KD, Caporale N, Visel M, Klimczak RR, Schaffer DV, Flannery JG (2009) Inner limiting membrane barriers to AAVmediated retinal transduction from the vitreous. Mol Ther 17(12):2096-2102
19. Koerber JT, Klimczak R, Jang JH, Dalkara D, Flannery JG, Schaffer DV (2009) Molecular evolution of adeno-associated virus for enhanced glial gene delivery. Mol Ther 17(12):2088-2095
20. Rohr UP, Wulf MA, Stahn S, Steidl U, Haas R, Kronenwett R (2002) Fast and reliable titration of recombinant adeno-associated virus type-2 using quantitative real-time PCR. J Virol Methods 106(1):81-88 (Pubitemid 35279652)
21. Aurnhammer C, Haase M, Muether N, Hausl M, Rauschhuber C, Huber I, Nitschko H, Busch U, Sing A, Ehrhardt A, Baiker AE (2011) An universal real-time PCR for the detection and quanti fi cation of adeno-associated virus serotype 2 derived inverted terminal repeat sequences. Hum Gene Ther Med 23(1): 18-28
22. Kozak M (1987) An analysis of 5 ¢ -noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acid Res 15(20):8125-8148
23. Loeb JE, Cordier WS, Harris ME, Weitzman MD, Hope TJ (1999) Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: Implications for gene therapy. Hum Gene Ther 10(14): 2295-2305 (Pubitemid 29459840)
24. Choi VW, Asokan A, Haberman RA, Samulski RJ (2007) Production of recombinant adenoassociated viral vectors. Curr Protoc Hum Genet Chapter 12: Unit 12.9
25. Grieger JC, Choi VW, Samulski RJ (2006) Production and characterization of adenoassociated viral vectors. Nat Protoc 1(3): 1412-1428
26. Ayuso E, Mingozzi F, Montane J, Leon X, Anguela XM, Haurigot V, Edmonson SA, Africa L, Zhou S, High KA, Bosch F, Wright JF (2010) High AAV vector purity results in serotype- and tissue-independent enhancement of transduction ef fi ciency. Gene Ther 17(4): 503-510
27. Vandenberghe LH, Xiao R, Lock M, Lin J, Korn M, Wilson JM (2010) Ef fi cient serotypedependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Hum Gene Ther 21(10): 1251-1257
28. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N (1999) Recombinant adeno-associated virus puri fi cation using novel methods improves infectious titer and yield. Gene Ther 6(6):973-985 (Pubitemid 29295202)
29. Hauswirth WW, Lewin AS, Zolotukhin S, Muzyczka N (2000) Production and puri fi cation of recombinant adeno-associated virus. Methods Enzymol 316:743-761 (Pubitemid 30235704)
30. Lock M, McGorray S, Auricchio A, Ayuso E, Beecham EJ, Blouin-Tavel V, Bosch F, Bose M, Byrne BJ, Caton T, Chiorini JA, Chtarto A, Clark KR, Conlon T, Darmon C, Doria M, Douar A, Flotte TR, Francis JD, Francois A, Giacca M, Korn MT, Korytov I, Leon X, Leuchs B, Lux G, Melas C, Mizukami H, Moullier P, Muller M, Ozawa K, Philipsberg T, Poulard K, Raupp C, Riviere C, Roosendaal SD, Samulski RJ, Soltys SM, Surosky R, Tenenbaum L, Thomas DL, van Montfort B, Veres G, Wright JF, Xu Y, Zelenaia O, Zentilin L, Snyder RO (2010) Characterization of a recombinant adeno-associated virus type 2 Reference Standard Material. Hum Gene Ther 21(10):1273-1285
31. Zolotukhin S, Potter M, Zolotukhin I, Sakai Y, Loiler S, Fraites TJ Jr, Chiodo VA, Phillipsberg T, Muzyczka N, Hauswirth WW, Flotte TR, Byrne BJ, Snyder RO (2002) Production and puri fi cation of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. Methods 28(2):158-167 (Pubitemid 35341079)